Get started
Author

Sally Yan Bai

The nitroreductase prodrug SN 28343 enhances the potency of systemically administered armed oncolytic adenovirus ONYX-411NTR
2007 · D C Singleton, D Li, et al. · Cancer Gene Therapy · 53
Influence of a Basic Side Chain on the Properties of Hypoxia-Selective Nitro Analogues of the Duocarmycins: Demonstration of Substantial Anticancer Activity in Combination with Irradiation or Chemotherapy
2017 · Moana Tercel, Ho H. Lee, et al. · Journal of Medicinal Chemistry · 36
Integrin αvβ5 as a biomarker for the assessment of non‐small cell lung cancer metastasis and overall survival
2014 · Sally Yan Bai, Nuo Xu, et al. · The Clinical Respiratory Journal · 26
PDF
Bioreductive prodrug PR-104 improves the tumour distribution and titre of the nitroreductase-armed oncolytic adenovirus ONYX-411NTR leading to therapeutic benefit
2021 · Dean C. Singleton, Alexandra M. Mowday, et al. · Cancer Gene Therapy · 11
A phase 3, randomized study of adjuvant rilvegostomig plus chemotherapy in resected biliary tract cancer: ARTEMIDE-Biliary01.
2024 · Jia Fan, Tanios S. Bekaii-Saab, et al. · Journal of Clinical Oncology · 10
PDF
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate
2022 · Ji Min Kim, Binnari Kim, et al. · Molecular Diagnosis & Therapy · 4
Interchangeability of PD-L1 laboratory-developed test by 22C3 antibody concentrate among ihc platforms in gastric cancer
2020 · Jimin Kim, Binnari Kim, et al. · Pathology · 1
PDF
The prognostic significance of MET overexpression in Chinese patients with gastric adenocarcinoma.
2014 · Jin Li, Chenchen Wang, et al. · Journal of Clinical Oncology · 1
300 POSTER Oncolytic adenovirus ONYX-411NTR enhances the antitumour efficacy of the bioreductive alkylator prodrug PR-104
2008 · D.C. Singleton, S.P. Syddall, et al. · European Journal of Cancer Supplements · 1
Works count: 9
Citation count: 143
H-index: 5
I10-index: 5
Year
Topic
Type